Page last updated: 2024-11-13

deitiforin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

deitiforin: Russian drug [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73349607
CHEMBL ID2442223
MeSH IDM0167347

Synonyms (2)

Synonym
CHEMBL2442223
deitiforin
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID778916Selectivity index, ratio of CTD50 for MDCK cells to EC50 for Influenza A virus California/07/09(H1N1) pdm09 infected in MDCK cells2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity.
AID778918Cytotoxicity against MDCK cells after 48 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity.
AID778917Antiviral activity against Influenza virus A/California/07/09 (H1N1)pdm09 infected in MDCK cells assessed as inhibition of viral replication incubated for 1 hr prior to viral infection measured after 48 hrs by hemagglutination reaction2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]